Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · June 15, 2023

Pen-Administered Low-Dose Dasiglucagon vs Usual Care for the Prevention and Treatment of Non-Severe Hypoglycaemia in People With Type 1 Diabetes During Free-Living Conditions



Additional Info

Disclosure statements are available on the authors' profiles:

Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial
Diabetologia 2023 Jul 01;66(7)1208-1217, C Laugesen, AG Ranjan, S Schmidt, K Nørgaard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading